Valued at a market cap of $133.6 billion, Boston Scientific Corporation (BSX) develops, manufactures, and markets medical ...

Boston Scientific (NYSE: BSX) today announced that it appointed Kathleen Van Vlierberghe as VP for Peripheral Interventions ...

MARLBOROUGH, Mass., Nov. 15, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced the close of its acquisition of Axonics, Inc. (Nasdaq: AXNX), a medical technology ...

The update followed a higher than expected number of reports of esophageal injury after catheter ablation procedures for ...

Boston Scientific is expanding its presence in cancer treatment as the Marlborough-based medical device manufacturer intends to acquire Intera Oncology, a Newton-based medical device company ...

Boston Scientific has agreed to buy privately held ... that affects nearly 38 million people around the world. The Marlborough, Mass., medical-technology company said Cortex received Food and ...

Learn more about whether Baxter International Inc. or Boston Scientific Corporation is a better investment based on AAII's A+ ...

MARLBOROUGH, Mass., Nov. 25, 2024 /PRNewswire/ -- Boston Scientific Corporation (NYSE: BSX) today announced it has entered into a definitive agreement to acquire Intera Oncology® Inc., a ...

Boston Scientific Corporation (BSX) develops, manufactures, and markets medical devices for use in various interventional medical specialties. The Marlborough, Massachusetts-based company offers ...